Emerging Agents in the Pipeline for Merkel Cell Carcinoma
2 Tampilan
administrator
07/17/23
Howard L. Kaufman, MD, FACS, chief surgical officer and associate director for clinical science at Rutgers Cancer Institute of New Jersey, discusses emerging agents in the pipeline for Merkel cell carcinoma.
Menampilkan lebih banyak
Komentar Facebook
Tidak ada komentar yang ditemukan